MHY 908

MHY 908 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Products Intro: Product Name:MHY908
CAS:1393371-39-5
Package:10 mg;5 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Products Intro: Product Name:MHY 908
CAS:1393371-39-5
Purity:99% Package:500μg;1mg;5mg
Company Name: Shanghai Hongye Biotechnology Co. Ltd  
Tel: 400-9205774
Email: sales@glpbio.cn
Products Intro: Product Name:MHY908
CAS:1393371-39-5
Purity:>98% Package:1mg;10mg;50mg;100mg;
Company Name: BOC Sciences  
Tel:
Email: info@bocsci.com
Products Intro: Product Name:MHY 908
CAS:1393371-39-5
Purity:99% Remarks:MHY 908 is a dual PPARα/γ agonist and a melanogenesis inhibitor that suppresses mushroom tyrosinase activity (IC50 value 8.19 μM). MHY908 exhibits more potent activation of PPARα and PPARγ than fenofi
Company Name: ChemeGen(Shanghai) Biotechnology Co.,Ltd.  
Tel: 18818260767
Email: sales@chemegen.com
Products Intro: Product Name:MHY908
CAS:1393371-39-5
Purity:98% Package:10 mg;50 mg;100 mg;500 mg;1 g;5 g;10 g
MHY 908 Basic information
Product Name:MHY 908
Synonyms:MHY 908;MHY908,MHY-908;Propanoic acid, 2-[4-(5-chloro-2-benzothiazolyl)phenoxy]-2-methyl-
CAS:1393371-39-5
MF:C17H14ClNO3S
MW:347.82
EINECS:
Product Categories:
Mol File:1393371-39-5.mol
MHY 908 Structure
MHY 908 Chemical Properties
Boiling point 523.6±58.0 °C(Predicted)
density 1.381±0.06 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 25 mg/ml; DMF:PBS (pH 7.2) (1:8): 0.1 mg/ml; DMSO: 10 mg/ml; Ethanol: 1 mg/ml
form A crystalline solid
pka3.15±0.10(Predicted)
Safety Information
MSDS Information
MHY 908 Usage And Synthesis
DescriptionMHY908 is a dual agonist of peroxisome proliferator-activated receptor α (PPARα) and PPARγ that increases transcriptional activity of PPARα and PPARγ in a luciferase reporter assay in AC2F rat liver cells when used at a concentration of 5 μM. In vivo, MHY908 (3 mg/kg per day) reduces serum glucose, triglyceride, and insulin levels and improves hepatic steatosis by reducing hepatic triglyceride levels and lipid droplet accumulation in db/db mice and 20-month-old rats. It reduces peroxynitrite and COX-2 levels, reactive oxygen species (ROS) production, and Akt phosphorylation in isolated kidney from 20-month-old rats when administered at a dose of 3 mg/kg. MHY908 inhibits mushroom tyrosinase (IC50 = 8.19 μM). It also inhibits increases in melanin content in α-melanocyte stimulating hormone-induced B16/F10 murine melanoma cells when used at a concentration of 10 μM.
UsesMHY908 is a dual agonist of PPARα and PPARγ.
MHY 908 Preparation Products And Raw materials
Tag:MHY 908(1393371-39-5) Related Product Information